Zobrazeno 1 - 10
of 20
pro vyhledávání: '"11"'
Autor:
Carmen Sanmartín, Juan M. Irache, Juana Schwartz, Socorro Espuelas, Alba Calvo, Esther Moreno, Iñigo Navarro-Blasco, Elena González-Peñas
Publikováno v:
Pharmaceutics
Volume 11
Issue 11
Volume 11
Issue 11
The oral administration of dapsone (DAP) for the treatment of cutaneous leishmaniasis (CL) is effective, although serious hematological side effects limit its use. In this study, we evaluated this drug for the topical treatment of CL. As efficacy dep
Autor:
Youseong Kim, Shayan Fakhraei Lahiji, Jeesu Jang, Daniel Junmin Um, Huisuk Yang, Hyungil Jung
Publikováno v:
Pharmaceutics
Volume 11
Issue 11
Pharmaceutics, Vol 11, Iss 11, p 549 (2019)
Volume 11
Issue 11
Pharmaceutics, Vol 11, Iss 11, p 549 (2019)
Alopecia, characterized by hair follicle blockage and hair loss, disrupts the normal cycle of hair growth. Although not a life-threatening condition, a growing body of evidence suggests that the psychological state of individuals experiencing alopeci
Autor:
Babu V. Sajesh, Donald W. Miller, Ngoc H. On, Neal M. Davies, Brian M. Kopec, Magimairajan Issai Vanan, Pema-Tenzin Puno, Ted M. Lakowski, Han-Dong Sun, Ryan Lillico, Wei-Guang Wang, Samaa Alrushaid, Teruna J. Siahaan, Refaat Omar
Publikováno v:
Pharmaceutics, Vol 11, Iss 9, p 481 (2019)
Pharmaceutics
Volume 11
Issue 9
Pharmaceutics
Volume 11
Issue 9
The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient concentrations. While transient disruption of the BBB has been used to enhance chemotherapeutic e
Autor:
Éanna Forde, Graeme Kelly, Marc Devocelle, Ronan MacLoughlin, Louise Sweeney, Deirdre Fitzgerald-Hughes
Publikováno v:
Pharmaceutics
Volume 11
Issue 5
Pharmaceutics, Vol 11, Iss 5, p 239 (2019)
Volume 11
Issue 5
Pharmaceutics, Vol 11, Iss 5, p 239 (2019)
Background: There has been considerable interest in the use of antimicrobial peptides (AMPs) as antimicrobial therapeutics in many conditions including cystic fibrosis (CF). The aim of this study is to determine if the prodrugs of AMPs (pro-AMPs) can
Publikováno v:
Pharmaceutics
Volume 11
Issue 4
Pharmaceutics, Vol 11, Iss 4, p 153 (2019)
Pharmaceutics. 2019, vol. 11, issue 4, p. 1-10.
Volume 11
Issue 4
Pharmaceutics, Vol 11, Iss 4, p 153 (2019)
Pharmaceutics. 2019, vol. 11, issue 4, p. 1-10.
Medical aerosols are key elements of current chronic obstructive pulmonary disease (COPD) therapy. Therapeutic effects are conditioned by the delivery of the right amount of medication to the right place within the airways, that is, to the drug recep
Autor:
Couce Ml, Blanco Méndez J, Colón Mejeras C, González Af, Beiras Iglesias A, Otero Espinar Fj, Shunji Tomatsu, Herrero Filgueira C, Luzardo Álvarez A, Álvarez Jv
Publikováno v:
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Pharmaceutics
Pharmaceutics, Vol 11, Iss 10, p 522 (2019)
Volume 11
Issue 10
instname
Pharmaceutics
Pharmaceutics, Vol 11, Iss 10, p 522 (2019)
Volume 11
Issue 10
Mucopolysaccharidosis IVA (Morquio A) is a rare inherited metabolic disease caused by deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate-sulfatase (GALNS). Until now, treatments employed included hematopoietic stem cell transplantation
Autor:
Daan J Touw, Max Beugeling, Gerard Dijkstra, Silke Posthumus, Henderik W. Frijlink, Pauline Koopmans, Jos G. W. Kosterink, Bahez Gareb
Publikováno v:
Pharmaceutics
Volume 11
Issue 9
Pharmaceutics, Vol 11, Iss 9, p 428 (2019)
Pharmaceutics, 11(9):428. MDPI AG
Volume 11
Issue 9
Pharmaceutics, Vol 11, Iss 9, p 428 (2019)
Pharmaceutics, 11(9):428. MDPI AG
Infliximab (IFX) is an intravenously administered monoclonal antibody antagonizing the effects of tumor necrosis factor-alpha (TNF) systemically and is efficacious in the treatment of inflammatory bowel disease (IBD). However, studies suggest that th
Publikováno v:
Pharmaceutics
Volume 11
Issue 4
Pharmaceutics, Vol 11, Iss 4, p 189 (2019)
Volume 11
Issue 4
Pharmaceutics, Vol 11, Iss 4, p 189 (2019)
We aimed to assess the potential herb&ndash
drug interactions between Korean red ginseng extract (RGE) and metformin in rats in terms of the modulation of metformin transporters, such as organic cation transporter (Oct), multiple toxin and extru
drug interactions between Korean red ginseng extract (RGE) and metformin in rats in terms of the modulation of metformin transporters, such as organic cation transporter (Oct), multiple toxin and extru
Autor:
Patrícia Fraga, Marco Cavaco, Vera Neves, David Andreu, Miguel A. R. B. Castanho, Javier Valle
Publikováno v:
Pharmaceutics
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1863, p 1863 (2021)
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1863, p 1863 (2021)
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Brea
Brea
Autor:
Anroop B. Nair, Nagaraja Sreeharsha, Chandramouli Ramnarayanan, Rana B. Bakhaidar, Lenah S. Binmahfouz, Hibah M. Aldawsari, Sabna Kotta, Shaimaa M Badr-Eldin
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 1851, p 1851 (2021)
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1851, p 1851 (2021)
Volume 13
Issue 11
Excessive architectural re-modeling of tissues in pulmonary fibrosis due to proliferation of myofibroblasts and deposition of extracellular matrix adversely affects the elasticity of the alveoli and lung function. Progressively destructive chronic in